Analysis: How COVID-19 Vaccination Rates Vary Across Different Communities

October 20, 2021Garrett SchmittNo CommentsBiden administration, BioNTech, CMS, community health, Coronavirus, COVID, COVID-19, COVID-19 pandemic, COVID-19 vaccine, EUA, FDA, Janssen, Johnson & Johnson, Medicare, Moderna, Pfizer, Pfizer-BioNTech

The year of 2020 was dominated by the news of how COVID-19 spread around the world, and how life has been changed by the disruption of this pandemic. We have witnessed the journeys of battling the disease, dedication and sacrifices by the front-line heroes, and the emotional roller coaster of wondering when this pandemic would…

Recent Posts

  • ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
  • How value-based payment models are reshaping physician practices — and what comes next
  • Fraud, Waste, and Abuse—A Value-Based Care Risk Hiding from Health Care Leaders
  • From value-based care to AI: Healthcare leaders on sustainability strategy
  • RECORDED WEBINAR: TEAM and CJR-X: How universal mandatory risk will change value-based care
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us